-
DREAM: On hallucinations in AI-generated content for nuclear medicine imaging
Authors:
Menghua Xia,
Reimund Bayerlein,
Yanis Chemli,
Xiaofeng Liu,
Jinsong Ouyang,
Georges El Fakhri,
Ramsey D. Badawi,
Quanzheng Li,
Chi Liu
Abstract:
Artificial intelligence-generated content (AIGC) has shown remarkable performance in nuclear medicine imaging (NMI), offering cost-effective software solutions for tasks such as image enhancement, motion correction, and attenuation correction. However, these advancements come with the risk of hallucinations, generating realistic yet factually incorrect content. Hallucinations can misrepresent anat…
▽ More
Artificial intelligence-generated content (AIGC) has shown remarkable performance in nuclear medicine imaging (NMI), offering cost-effective software solutions for tasks such as image enhancement, motion correction, and attenuation correction. However, these advancements come with the risk of hallucinations, generating realistic yet factually incorrect content. Hallucinations can misrepresent anatomical and functional information, compromising diagnostic accuracy and clinical trust. This paper presents a comprehensive perspective of hallucination-related challenges in AIGC for NMI, introducing the DREAM report, which covers recommendations for definition, representative examples, detection and evaluation metrics, underlying causes, and mitigation strategies. This position statement paper aims to initiate a common understanding for discussions and future research toward enhancing AIGC applications in NMI, thereby supporting their safe and effective deployment in clinical practice.
△ Less
Submitted 18 June, 2025; v1 submitted 16 June, 2025;
originally announced June 2025.
-
Anatomically and Metabolically Informed Diffusion for Unified Denoising and Segmentation in Low-Count PET Imaging
Authors:
Menghua Xia,
Kuan-Yin Ko,
Der-Shiun Wang,
Ming-Kai Chen,
Qiong Liu,
Huidong Xie,
Liang Guo,
Wei Ji,
Jinsong Ouyang,
Reimund Bayerlein,
Benjamin A. Spencer,
Quanzheng Li,
Ramsey D. Badawi,
Georges El Fakhri,
Chi Liu
Abstract:
Positron emission tomography (PET) image denoising, along with lesion and organ segmentation, are critical steps in PET-aided diagnosis. However, existing methods typically treat these tasks independently, overlooking inherent synergies between them as correlated steps in the analysis pipeline. In this work, we present the anatomically and metabolically informed diffusion (AMDiff) model, a unified…
▽ More
Positron emission tomography (PET) image denoising, along with lesion and organ segmentation, are critical steps in PET-aided diagnosis. However, existing methods typically treat these tasks independently, overlooking inherent synergies between them as correlated steps in the analysis pipeline. In this work, we present the anatomically and metabolically informed diffusion (AMDiff) model, a unified framework for denoising and lesion/organ segmentation in low-count PET imaging. By integrating multi-task functionality and exploiting the mutual benefits of these tasks, AMDiff enables direct quantification of clinical metrics, such as total lesion glycolysis (TLG), from low-count inputs. The AMDiff model incorporates a semantic-informed denoiser based on diffusion strategy and a denoising-informed segmenter utilizing nnMamba architecture. The segmenter constrains denoised outputs via a lesion-organ-specific regularizer, while the denoiser enhances the segmenter by providing enriched image information through a denoising revision module. These components are connected via a warming-up mechanism to optimize multitask interactions. Experiments on multi-vendor, multi-center, and multi-noise-level datasets demonstrate the superior performance of AMDiff. For test cases below 20% of the clinical count levels from participating sites, AMDiff achieves TLG quantification biases of -26.98%, outperforming its ablated versions which yield biases of -35.85% (without the lesion-organ-specific regularizer) and -40.79% (without the denoising revision module).
△ Less
Submitted 17 March, 2025;
originally announced March 2025.
-
Dose-aware Diffusion Model for 3D PET Image Denoising: Multi-institutional Validation with Reader Study and Real Low-dose Data
Authors:
Huidong Xie,
Weijie Gan,
Reimund Bayerlein,
Bo Zhou,
Ming-Kai Chen,
Michal Kulon,
Annemarie Boustani,
Kuan-Yin Ko,
Der-Shiun Wang,
Benjamin A. Spencer,
Wei Ji,
Xiongchao Chen,
Qiong Liu,
Xueqi Guo,
Menghua Xia,
Yinchi Zhou,
Hui Liu,
Liang Guo,
Hongyu An,
Ulugbek S. Kamilov,
Hanzhong Wang,
Biao Li,
Axel Rominger,
Kuangyu Shi,
Ge Wang
, et al. (2 additional authors not shown)
Abstract:
Reducing scan times, radiation dose, and enhancing image quality for lower-performance scanners, are critical in low-dose PET imaging. Deep learning techniques have been investigated for PET image denoising. However, existing models have often resulted in compromised image quality when achieving low-count/low-dose PET and have limited generalizability to different image noise-levels, acquisition p…
▽ More
Reducing scan times, radiation dose, and enhancing image quality for lower-performance scanners, are critical in low-dose PET imaging. Deep learning techniques have been investigated for PET image denoising. However, existing models have often resulted in compromised image quality when achieving low-count/low-dose PET and have limited generalizability to different image noise-levels, acquisition protocols, and patient populations. Recently, diffusion models have emerged as the new state-of-the-art generative model to generate high-quality samples and have demonstrated strong potential for medical imaging tasks. However, for low-dose PET imaging, existing diffusion models failed to generate consistent 3D reconstructions, unable to generalize across varying noise-levels, often produced visually-appealing but distorted image details, and produced images with biased tracer uptake. Here, we develop DDPET-3D, a dose-aware diffusion model for 3D low-dose PET imaging to address these challenges. Collected from 4 medical centers globally with different scanners and clinical protocols, we evaluated the proposed model using a total of 9,783 18F-FDG studies with low-dose levels ranging from 1% to 50%. With a cross-center, cross-scanner validation, the proposed DDPET-3D demonstrated its potential to generalize to different low-dose levels, different scanners, and different clinical protocols. As confirmed with reader studies performed by board-certified nuclear medicine physicians, experienced readers judged the images to be similar or superior to the full-dose images and previous DL baselines based on qualitative visual impression. Lesion-level quantitative accuracy was evaluated using a Monte Carlo simulation study and a lesion segmentation network. The presented results show the potential to achieve low-dose PET while maintaining image quality. Real low-dose scans was also included for evaluation.
△ Less
Submitted 16 June, 2025; v1 submitted 2 May, 2024;
originally announced May 2024.
